SoftBank Group announced on Wednesday that it has reached an agreement to acquire the robotics division of Swiss engineering company ABB for $5.4 billion.
Ab&B Bio-Tech, a vaccine development company focused on influenza and rabies, saw its shares surge nearly 170% on their Hong Kong Stock Exchange debut.
08 Oct 2025-11:20
11 Aug 2025-16:05
